Alnylam Pharmaceuticals, Inc.

KORNITZER CAPITAL MANAGEMENT INC /KS ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

11,114

Value ($000)

4,419

Weight

0.1%

2014 Q1 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	4,419	0.1%	11,114	12/31/2025
2025 Q3	10/31/2025	10,802	0.2%	23,689	9/30/2025
2025 Q2	7/31/2025	7,554	0.2%	23,164	6/30/2025
2025 Q1	5/2/2025	540	0.0%	2,000	3/31/2025
2023 Q3	10/31/2023	3,896	0.1%	22,000	9/30/2023
2023 Q2	8/1/2023	4,179	0.1%	22,000	6/30/2023
2022 Q4	2/2/2023	257	0.0%	1,080	12/31/2022
2022 Q3	11/3/2022	216	0.0%	1,080	9/30/2022
2022 Q1	4/27/2022	549	0.0%	3,360	3/31/2022
2021 Q4	2/1/2022	570	0.0%	3,360	12/31/2021
2021 Q3	11/3/2021	634	0.0%	3,360	9/30/2021
2021 Q2	7/30/2021	570	0.0%	3,360	6/30/2021
2021 Q1	4/30/2021	813	0.0%	5,760	3/31/2021
2020 Q4	1/29/2021	8,072	0.1%	62,105	12/31/2020
2020 Q3	10/30/2020	13,761	0.3%	94,515	9/30/2020
2020 Q2	8/3/2020	9,081	0.2%	61,313	6/30/2020
2020 Q1	4/30/2020	731	0.0%	6,720	3/31/2020
2019 Q4	1/31/2020	774	0.0%	6,720	12/31/2019
2014 Q2	7/30/2014	3,787	0.0%	59,950	6/30/2014
2014 Q1	4/29/2014	3,490	0.0%	51,975	3/31/2014